Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Nutriband New Year Letter to Shareholders
-
Nutriband signs agreement to sell majority stake in Pocono for $5M
-
-
Fentanyl designation Response
-
Longeveron granted US patent for method of treating female sexual dysfunction using its proprietary stem cell therapy laromestrocel.
-
Calgon Carbon announces new patent for technology to remove of PFAS from water using reactivated carbon.
-
Chicago, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Blank Rome LLP announces the addition of Ferlillia V. Roberson, a Chambers-ranked intellectual property litigator, as a partner in its Chicago office....
-
Longeveron granted Canadian patent for method of using stem cells to treat patients with aging-related frailty and also for the treatment of NIDCM.
-
Longeveron issued US patent for method of treating aging-related frailty in patients with inflammaging using its proprietary stem cell therapy.
-
ORLANDO, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has announced that Company founder, Gareth Sheridan has returned as Company CEO. During the period of...